He argued that the most transformative advances will come not from GLP-1 monotherapy, but from combinations that integrate multiple gut hormones and perhaps even extend beyond metabolism to address obesitys comorbidities
Recent advances in monoclonal antibody therapies targeting A plaques (e.g., donanemab, lecanemab) have shown potential, but they also pose significant risks, such as amyloid-related imaging abnormalities with edema (ARIA-E), highlighting the need for safer and more effective alternatives
If you're carb counting or using closed-loop insulin delivery, mention to your diabetes care team that you've started a GLP-1 medication so you can adjust your approach if needed
Cedars-Sinai explains that this describes a condition where the body attacks its own glands that produce moisture, leaving behind dryness in the skin, eyes and mouth
For research handling it is typically reconstituted with bacteriostatic water
Medical weight loss is a medically supervised, nonsurgical weight loss solution for individuals who want assistance with more than just diet and exercise to reduce weight